Research Database

20 studies found

Positive

85.0%

Negative

10.0%

Inconclusive

5.0%

Page 1 of 1

NegativeAnimal Study - Veterinary Clinical Trial

Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum

2022

AddictionCannabis Adverse EffectsCannabis Hyperemesis Syndrome+5

PositiveReview/Other

Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum

2022

Cannabis Adverse Effects

PositiveReview/Other

Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

2022

Cannabis Adverse Effects

PositiveReview/Other

The Effectiveness of Common Cannabis Products for Treatment of Nausea

2022

Chemotherapy-induced Nausea & Vomiting

PositiveReview/Other

Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

2021

Nausea and Vomiting

PositiveReview/Other

Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida

2021

Arthritis - Osteoarthritis

PositiveReview/Other

Medicinal Use of Cannabis in Children and Pregnant Women

2020

ADD and ADHD

PositiveReview/Other

The use of cannabis for Hyperemesis Gravidarum (HG)

2020

Morning sickness

PositiveAnimal Study -

Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

2020

Nausea and Vomiting

PositiveAnimal Study -

Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

2020

Nausea and Vomiting

InconclusiveAnimal Study - Veterinary Clinical Trial

Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum

2019

Morning sickness

PositiveAnimal Study -

Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

2017

Anxiety

NegativeReview/Other

Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i

2014

Morning sickness

PositiveAnimal Study -

Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

2013

Nausea and Vomiting

PositiveAnimal Study -

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

2013

Nausea and Vomiting

PositiveReview/Other

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

2007

Nausea and Vomiting

PositiveReview/Other

Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.

2006

Morning sickness

PositiveMeta-analysis

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

2003

Nausea and Vomiting

PositiveReview/Other

Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study

1994

Morning sickness

PositiveReview/Other

Newborn outcomes with maternal marihuana use in Jamaican women

1988

Morning sickness

Command Palette

Research Database

Pneumopericardium, Epidural Pneumatosis, and Muscular Emphysema: Rare Complications of Spontaneous Pneumomediastinum Due to Refractory Hyperemesis Gravidarum

Patterns of Use and Self-reported Effectiveness of Cannabis for Hyperemesis Gravidarum

Cannabidiol Interferes with Establishment of Δ 9-Tetrahydrocannabinol-Induced Nausea Through a 5-HT 1A Mechanism

The Effectiveness of Common Cannabis Products for Treatment of Nausea

Therapeutic Potential of Cannabidiol, Cannabidiolic Acid, and Cannabidiolic Acid Methyl Ester as Treatments for Nausea and Vomiting

Mixed methods study of the potential therapeutic benefits from medical cannabis for patients in Florida

Medicinal Use of Cannabis in Children and Pregnant Women

The use of cannabis for Hyperemesis Gravidarum (HG)

Effect of combined doses of Δ 9-tetrahydrocannabinol and cannabidiol or tetrahydrocannabinolic acid and cannabidiolic acid on acute nausea in male Sprague-Dawley rats

Evaluation of repeated or acute treatment with cannabidiol (CBD), cannabidiolic acid (CBDA) or CBDA methyl ester (HU-580) on nausea and/or vomiting in rats and shrews

Plasma anandamide and related n-acylethanolamide levels are not elevated in pregnancies complicated by hyperemesis gravidarum

Cannabidiolic acid methyl ester, a stable synthetic analogue of cannabidiolic acid, can produce 5‐HT1A receptor‐mediated suppression of nausea and anxiety in rats

Marijuana Use and Maternal Experiences of Severe Nausea During Pregnancy in Hawai‘i

Tetrahydrocannabinolic acid reduces nausea-induced conditioned gaping in rats and vomiting in Suncus murinus.

Cannabidiolic acid prevents vomiting in Suncus murinus and nausea-induced behaviour in rats by enhancing 5-HT1A receptor activation.

Arvanil, anandamide and N-arachidonoyl-dopamine (NADA) inhibit emesis through cannabinoid CB1 and vanilloid TRPV1 receptors in the ferret

Survey of medicinal cannabis use among childbearing women: patterns of its use in pregnancy and retroactive self-assessment of its efficacy against 'morning sickness'.

Compositions comprising cannabinoids for treatment of nausea, vomiting, emesis, motion sickness or like conditions

Prenatal marijuana exposure and neonatal outcomes in Jamaica: an ethnographic study

Newborn outcomes with maternal marihuana use in Jamaican women